A novel identified pyroptosis-related prognostic signature of colorectal cancer

Colorectal cancer (CRC), one of the most common malignancies worldwide, leads to abundant cancer-related mortalities annually. Pyroptosis, a new kind of programmed cell death, plays a critical role in immune response and tumor progression. Our study aimed to identify a prognostic signature for CRC b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen Zheng, Zhaobang Tan
Formato: article
Lenguaje:EN
Publicado: AIMS Press 2021
Materias:
Acceso en línea:https://doaj.org/article/75368c0f40d447efb1b1e0785d500245
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:75368c0f40d447efb1b1e0785d500245
record_format dspace
spelling oai:doaj.org-article:75368c0f40d447efb1b1e0785d5002452021-11-29T02:35:56ZA novel identified pyroptosis-related prognostic signature of colorectal cancer10.3934/mbe.20214331551-0018https://doaj.org/article/75368c0f40d447efb1b1e0785d5002452021-10-01T00:00:00Zhttps://www.aimspress.com/article/doi/10.3934/mbe.2021433?viewType=HTMLhttps://doaj.org/toc/1551-0018Colorectal cancer (CRC), one of the most common malignancies worldwide, leads to abundant cancer-related mortalities annually. Pyroptosis, a new kind of programmed cell death, plays a critical role in immune response and tumor progression. Our study aimed to identify a prognostic signature for CRC based on pyroptosis-related genes (PRGs). The difference in PRGs between CRC tissues and normal tissues deposited in the TCGA database was calculated by "limma" R package. The tumor microenvironment (TME) of CRC cases was accessed by the ESTIMATE algorithm. The prognostic PRGs were identified using Cox regression analysis. A least absolute shrinkage and selector operation (LASSO) algorithm was used to calculate the risk scores and construct a clinical predictive model of CRC. Gene Set Enrichment Analysis (GSEA) was performed for understanding the function annotation of the signature in the tumor microenvironment. We found that most PRGs were significantly dysregulated in CRC. Through the LASSO method, three key PRGs were selected to calculate the risk scores and construct the prognostic model for CRC. The risk score was an independent indicator of patient's prognosis. In addition, we classified the CRC patients into two clusters based on risk scores and discovered that CRC patients in cluster 2 underwent worse overall survival and owned higher expression levels of immune checkpoint genes in tumor tissues. In conclusion, our study identified a PRG-related prognostic signature for CRC, according to which we classified the CRC patients into two clusters with distinct prognosis and immunotherapy potential.Chen ZhengZhaobang TanAIMS Pressarticlecolorectal cancerpyroptosisprognosistcgaimmune infiltrationBiotechnologyTP248.13-248.65MathematicsQA1-939ENMathematical Biosciences and Engineering, Vol 18, Iss 6, Pp 8783-8796 (2021)
institution DOAJ
collection DOAJ
language EN
topic colorectal cancer
pyroptosis
prognosis
tcga
immune infiltration
Biotechnology
TP248.13-248.65
Mathematics
QA1-939
spellingShingle colorectal cancer
pyroptosis
prognosis
tcga
immune infiltration
Biotechnology
TP248.13-248.65
Mathematics
QA1-939
Chen Zheng
Zhaobang Tan
A novel identified pyroptosis-related prognostic signature of colorectal cancer
description Colorectal cancer (CRC), one of the most common malignancies worldwide, leads to abundant cancer-related mortalities annually. Pyroptosis, a new kind of programmed cell death, plays a critical role in immune response and tumor progression. Our study aimed to identify a prognostic signature for CRC based on pyroptosis-related genes (PRGs). The difference in PRGs between CRC tissues and normal tissues deposited in the TCGA database was calculated by "limma" R package. The tumor microenvironment (TME) of CRC cases was accessed by the ESTIMATE algorithm. The prognostic PRGs were identified using Cox regression analysis. A least absolute shrinkage and selector operation (LASSO) algorithm was used to calculate the risk scores and construct a clinical predictive model of CRC. Gene Set Enrichment Analysis (GSEA) was performed for understanding the function annotation of the signature in the tumor microenvironment. We found that most PRGs were significantly dysregulated in CRC. Through the LASSO method, three key PRGs were selected to calculate the risk scores and construct the prognostic model for CRC. The risk score was an independent indicator of patient's prognosis. In addition, we classified the CRC patients into two clusters based on risk scores and discovered that CRC patients in cluster 2 underwent worse overall survival and owned higher expression levels of immune checkpoint genes in tumor tissues. In conclusion, our study identified a PRG-related prognostic signature for CRC, according to which we classified the CRC patients into two clusters with distinct prognosis and immunotherapy potential.
format article
author Chen Zheng
Zhaobang Tan
author_facet Chen Zheng
Zhaobang Tan
author_sort Chen Zheng
title A novel identified pyroptosis-related prognostic signature of colorectal cancer
title_short A novel identified pyroptosis-related prognostic signature of colorectal cancer
title_full A novel identified pyroptosis-related prognostic signature of colorectal cancer
title_fullStr A novel identified pyroptosis-related prognostic signature of colorectal cancer
title_full_unstemmed A novel identified pyroptosis-related prognostic signature of colorectal cancer
title_sort novel identified pyroptosis-related prognostic signature of colorectal cancer
publisher AIMS Press
publishDate 2021
url https://doaj.org/article/75368c0f40d447efb1b1e0785d500245
work_keys_str_mv AT chenzheng anovelidentifiedpyroptosisrelatedprognosticsignatureofcolorectalcancer
AT zhaobangtan anovelidentifiedpyroptosisrelatedprognosticsignatureofcolorectalcancer
AT chenzheng novelidentifiedpyroptosisrelatedprognosticsignatureofcolorectalcancer
AT zhaobangtan novelidentifiedpyroptosisrelatedprognosticsignatureofcolorectalcancer
_version_ 1718407652341448704